Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
available at www.sciencedirect.com
journal homepage: www.europeanurology.com
Article info
Abstract
Article history:
Accepted February 2, 2011
Published online ahead of
print on February 11, 2011
Keywords:
Augmentation urethroplasty
Anterior urethral stricture
Bulbar urethroplasty
Dorsal onlay bulbar
urethroplasty
Ventral onlay bulbar
urethroplasty
Penile urethroplasty
# 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
* Corresponding author. H26 Royal Hallamshire Hospital, Shefeld S10 2JF, United Kingdom.
Tel. +447811337734.
E-mail address: mangeraaltaf@hotmail.com (A. Mangera).
1.
Introduction
0302-2838/$ see back matter # 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.eururo.2011.02.010
798
[()TD$FIG]
[()TD$FIG]
[()TD$FIG]
799
[()TD$FIG]
[()TD$FIG]
[()TD$FIG]
800
No.
treated
Follow-up, mo
Type
of graft
Morey and
McAninch
[11]
13
18
BM
Wessells and
McAninch [43]
27
23
BM 7
BLM 2
PS 21
Pansadoro
et al. [44]
20
BM
Andrich and
Mundy [14];
Andrich et al. [45]
29
4860
BM
Meneghini
et al. [46]
20
628
BM
Palminteri et al
[47]
24
18
BM
22
1254
BM
Kane et al
[49]
53
25
BM
Heinke et al
[50]
38
(30 bulbar)
22.8
BM
Pansadoro et al
[51]
41
BM
Elliott et al
[52]
60
47
BM
Dubey et al
[53]
18
45.7
6 PS
7 BM
6 BLM
Fichtner et al
[16]
32
(15 bulbar)
82.8
BM
18
50
BM
Berger et al
[17]
70.7
BM
Follow-up
method
Uroowmetry/
symptom score
Urethrography
3 and 12 mo
Uroowmetry
3 and 12 mo
Urethrography
23 wk and
3 and 12 mo
Uroowmetry
Urethrography
2 wk, 6 and
12 mo, then annually
Uroowmetry
3, 6, and 12 mo,
then annually
Urethrography
6 and 18 mo
Urethroscopy in
last 45 cases
Uroowmetry
3, 6, 9, and 12 mo
Urethrography 6 and 12 mo
Uroowmetry 4, 8,
and 12 mo, then annually
Urethrography 3 wk and 12 mo
Urethroscopy 12 mo
Uroowmetry 3 and 12 mo
Urethrography 3 and 12 mo
Uroowmetry 3, 6,
and 12 mo, then
annually with
symptom score
Urethrography
3 wk and 3 mo
Uroowmetry
6 and 12 mo and
PVRU estimation
Urethrography
3 wk; repeat
if deteriorating Qmax
Uroowmetry: periodic
Urethrography
2 wk, 6 and 12 mo,
then annually
Urethrography
3 wk, 3, 6, and 12 mo,
then as required
Uroowmetry
6 mo (all patients
performed ISD
16Ch up to 6 mo)
Urethrography
6, 12, and 18 mo,
then as required
Uroowmetry
6 and 12 mo with
symptom score
and PVRU estimation
Urethrography 3wk
Uroowmetry
3, 6, and 12 mo,
then annually
Urethrography
3wk, then as required
Uroowmetry
3, 6, and 12 mo, then annually
Urethrography 3 wk
Denition of failure
Success
rate, %
Any instrumentation
100
Any instrumentation;
radiographic presence
of stricture
100
100
90
Stricture recurrence
on urethrography
86
Development of symptoms
leading to urethrogram
or urethroscopy
86
80
95.8
Any instrumentation
86
Recurrence on radiologic
studies and requiring
intervention
94
81.6
Recurrence of symptoms
89
If stream reduced or
symptoms recurred
90
77.8
Symptomatic recurrence
87
Abnormal voiding
Need for intervention
87 (includes
5 penile)
If stream or symptoms
deteriorate
43
801
Table 1 (Continued )
Authors
No.
treated
Follow-up, mo
Type
of graft
Barbagli et al
[13]
17
42
BM
McLaughlin
et al. [55]
58
(48 reported)
29.6
BM
Palminteri
et al. [33]
21
SIS
10
31.2
SIS
12
8
15 (bulbopenile)
58.1
22.6
BM
BM
93
36
OM
15.25
OM
Dalela et al
[58]
13
16.4
BM
Follow-up
method
Uroowmetry
3, 6, and 12 mo,
then annually
Urethrography
3 wk, then as required
Urethroscopy as
required (Qmax <14 ml/s)
Symptom score at 12 mo
No routine urethrography
Urethroscopy if
deterioration in symptoms
Uroowmetry
4, 8, 12 mo, then annually
Urethrography
3 wk and 12 mo
or if Qmax <14 ml/s
Urethroscopy 3 and 12 mo
Urethrography every
3 mo until 12 mo,
then 6 monthly, then annually
If Qmax <15 ml/s
or IPSS >7, then urethrography
Urethrography 2 wk
Uroowmetry
Urethrography
3 wk, then if required
Urethral calibration
16Ch or urethroscopy
1, 3, 7, 10, 16 mo,
then annually
Uroowmetry
4, 8, 12 mo, then annually
Urethrography 23wk
IF Qmax <14 ml/s,
then urethrography
and urethroscopy
Uroowmetry
4, 8, 12 mo,
then annually
Urethrography
3 wk, 6 and 12 mo
If Qmax <14 ml/s, then
cystourethrography
and urethroscopy
Uroowmetry and
PVR estimation
Urethrography
if Qmax <14 ml/s
Urethroscopy
if Qmax <14 ml/s
Denition of failure
Success
rate, %
Any instrumentation
83
94
Stenosis on urethrography
90
Any instrumentation
Recurrence of stricture
83
89.9 (includes
bulbar)
Any instrumentation
91.4
Any instrumentation
100
84.6
100
BLM = bladder mucosa; BM = buccal mucosa; DVIU = direct vision internal urethrotomy; IPSS = International Prostate Symptom Score; ISD = intermittent selfdilatation; OM = oral mucosa; PS = penile skin; PVR = postvoid residual; PVRU = postvoiding residual urine; Qmax = maximum ow rate; SIS = small intestinal
submucosa.
802
No.
treated
Follow-up,
mo
Type of
graft
Barbagli
et al. [59]
20
46
SG
Barbagli
et al. [60]
37
21.5
(13.5 BM)
31 PS
6 BM
Pansadoro
et al. [44]
23
20
BM
Iselin and
Webster [61]
Barbagli
et al. [62]
29
19
40
43
PS or
BM
PS
Andrich and
Mundy
[14]
42
4860
BM
14
32
BM or PAS
Pansadoro et al
[51]
56
41
BM
Dubey et al
[53]
16
22
BM
51
BM or SG
Barbagli
et al. [64]
45
71
PS
40
70.7
BM
Raber et al
[65]
30
51
17 PS
13 (BM)
Dubey et al
[66]
41
36.2
BM
Barbagli et al
[13]
27
42
BM
Barbagli et al
[67]
16
BM
Donkov
et al. [68]
Simonato
et al. [37]
18
SIS
18
LM
Follow-up method
Uroowmetry 4, 8, 12 mo
Urethrography 23 wk
and once more and
if Qmax <14 ml/s
Uroowmetry 4, 8,
and 12 mo, then annually
Urethrography 3 wk,
repeat if Qmax <14 ml/s
Uroowmetry
Urethrography 2 wk,
6 and12 mo, then annually
Urethrography 3 wk,
3, 12, and 18 mo
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 23 wk,
4 mo, or if Qmax <14 ml/s
Uroowmetry 3, 6, and
12 mo, then annually
Urethrography 6 and 18 mo
Urethroscopy in last 45 cases
Uroowmetry 12 and 18 mo
Urethrography 3 wk, 12 and 18 mo
Uroowmetry: periodic
Urethrography 2 wk,
6 and 12 mo, then annually
Uroowmetry 6 mo
(all patients performed
ISD 16Ch up to 6 mo)
Urethrography 6, 12, and
18 mo, then as required
Uroowmetry 6 wk, 3 and 6 mo
Urethrography 6 mo
Uroowmetry 3, 6,
and 12 mo, then annually
Urethrography 3 wk,
then as required
Urethroscopy as
required (Qmax <14 ml/s)
Uroowmetry 3, 6,
and 12 mo, then annually
Urethrography 3 wk
Uroowmetry 6, 12,
and 18 mo with IPSS and IIEF scores
Urethrography 3 wk,
repeated if required
Urethroscopy as required
Uroowmetry 3, 6, 9,
and 12 mo with ongoing
urethral calibration (16 Ch)
Urethrography at 3 mo,
then as required
Uroowmetry 3, 6, and
12 mo, then annually
Urethrography 3 wk,
then as required
Urethroscopy as
required (Qmax <14 ml/s)
Uroowmetry 6 and 1 mo,
then annually
Urethrography 2 wk,
6 and 12 mo, then annually
Uroowmetry 6 wk, 18 mo
Urethroscopy 3 mo
Uroowmetry 3 and 12 mo
Urethrography 2 wk, 3 and 12 mo
Urethroscopy 3 and 12 mo
Denition of failure
Success
rate, %
Recurrence on
urethrography
95
Any instrumentation
92
(100% BM)
Stricture recurrence
on urethrography
100
Radiographic evidence
of recurrence
Any instrumentation
97
Development of
symptoms leading to
urethrogram or
urethroscopy to
conrm recurrence
Recurrence on
urethrography
Recurrence of symptoms
85
95
100
98
87
Restricturing on
urethrography
Any instrumentation
98
73
If stream or symptoms
deteriorate
95
76
(85)
Symptom recurrence
or inability to pass
16Ch catheter
90
Any instrumentation
85
Any instrumentation
100
Decreased ow rate
or stricture recurrence
Qmax <15 ml/s
Need for instrumentation
89
87.5
803
Table 2 (Continued )
Authors
No.
treated
Xu et al
[69]
12
57
BM
Palminteri
et al. [33]
21
SIS
Radopoulos
et al. [22]
16
49.9
PS
15
TV
21
4
53
22.6
BM
BM
22
41
111
OM
PS
15.25
OM
52
34
BM
11
17.7
LM
88
56
OM
LM
22
OM
21.7
PAS
Foinquinos
et al. [70]
Levine et al. [57]
Dubey et al. [8]
Barbagli
et al. [3]
Barbagli
et al. [15]
ORiordan
et al. [71]
Simonato
et al 2008 [72]
Kulkarni
et al. [26]
Kulkarni
et al. [74]
38
12
Follow-up,
mo
Type of
graft
30
23
BM
Schwentner
et al. [76]
42
57.2
29 PS
13 GS
22
10.5
BM
Follow-up method
Uroowmetry 1418 d,
36 mo (most patients)
Urethrography 1418 d
Urethroscopy in some
patients at 12 mo
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 3 wk and
12 mo or if Qmax <14 ml/s
Urethroscopy 3 and 12 mo
Uroowmetry 34 wk and 12 mo
Urethrography 34 wk and 12 mo
Uroowmetry and
urethrography
Urethrography 2 wk
Uroowmetry
Urethrography 3 wk, then if required
Urethral calibration 16Ch or
urethroscopy 1, 3, 7, 10, 16 mo,
then annually
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 23 wk
If Qmax <14 ml/s, then
urethrography and urethroscopy
Uroowmetry 4, 8, 12 mo, then annually
Urethrography 3 wk, 6 and 12 mo
If Qmax <14 ml/s, then
urethrography and urethroscopy
Urethrography 3 wk
Symptoms/interview
Uroowmetry 3 and 12 mo
Urethrography 2 wk, 3 and 12 mo
Urethroscopy 3 and 12 mo
Uroowmetry every
4, 8, 12 mo, then annually
Urethrography 3 wk
Urethrography if Qmax <12 ml/s
Uroowmetry 3 and 6 mo
Urethrography 3 wk, 3 and 6 mo
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 3 wk
If Qmax <14 ml/s then
urethrography and urethroscopy
Uroowmetry 3 and 6 mo,
annually in some patients
Urethrography 3 wk,
repeat if Qmax <14 ml/s
Uroowmetry/PVRU
3, 12 mo, then yearly
Urethrography 6 mo
Urethroscopy when required
Uroowmetry/PVR 3, 6, 9, and 12 mo
Urethrography at catheter
removal, then if required
Urethrography 34 wk
Urethroscopy if symptoms developed
Denition of failure
Any complication
Abnormal voiding
Any instrumentation
Evidence of stricture
on urethrography
Abnormal voiding
Any instrumentation
Evidence of stricture
on urethrography
Poor uroowmetry
Poor urethrography
Any instrumentation
Recurrence of stricture
Success
rate, %
77 (includes
tubularised
BLM
and
CM grafts)
100
81
100
86
89.9
(includes
penile)
Any instrumentation
77.3
65.8
Any instrumentation
100
Any instrumentation
86
81.8
Any instrumentation
91
83.3
(includes
penile)
92
Any instrumentation
100
Abnormal voiding,
stricture on urethrography
and need for instrumentation
94
Presence of symptoms
and low ow rate
90.5
Any instrumentation
83.3
BM = buccal mucosa; CM = colonic mucosa; DVIU = direct vision internal urethrotomy; GS = groin skin graft; IIEF = International Index of Erectile Dysfunction;
IPSS = International Prostate Symptom Score; ISD = intermittent self-dilatation; LM = lingual mucosa; OM = oral mucosa; PAS = postauricular skin graft;
PS = penile skin; PVR = postvoid residual; PVRU = postvoid residual urine; Qmax = maximum ow rate; SG = full-thickness skin graft; SIS = small intestinal
submucosa; TV = tunica vaginalis.
804
2.
Evidence acquisition
Evidence synthesis
3.1.
Most of the published literature relates to bulbar urethroplasty. Traditionally urethroplasty is performed as a ventral
onlay, with the corpus spongiosum either excised and
reconstructed using a free graft applied to a dorsal native
urethral roof strip or incised in the midline over the
stricture to perform a ventral stricturotomy, with the free
graft applied to augment the urethra [11]. Ideally the corpus
spongiosum is closed over the graft to provide a wellvascularised bed.
Barbagli et al described the dorsal onlay graft for
augmentation urethroplasty in 1996 [12]. The urethra is
mobilised intact and the stricturotomy is performed
dorsally. It has since found widespread support. The
suggested benefits are less bleeding from the thinner dorsal
spongiosum and application of the graft to the tunica
albuginea of the corpora cavernosa, allowing a more stable
base to allow better fixation of the graft, facilitating better
acquisition of a richer blood supply and reducing contracture during healing. Also there should be a theoretically
reduced risk of sacculation of the graft under pressure from
voiding and thus a reduced risk of diverticulum formation.
The lateral approach was described by Barbagli and
colleagues in patients with bulbar strictures where a
ventral urethrotomy may have led to serious bleeding
No. treated
Follow-up,
mo
Type of graft
Barbagli et al
[13]
42
BM
6 (same patients
as above)
77
OM
Follow-up method
Denition of
failure
Success
rate, %
Need for
instrumentation
83
Need for
instrumentation
83
No. treated
Follow-up,
mo
Type of graft
36
BM
2460+
BM
Follow-up method
Metro et al
[79]
Andrich et al. [21]
14
63.6
20
Fichtner et al
[16]
17
82.8
BM
Dubey et al
[66]
16
36.2
BM
Dubey et al
[80]
25
32.5
BM
50
BM
1
3 (bulbopenile)
21
SIS
9
31 (bulbopenile)
31.2
SIS
49.9
PS
TV
13
45
BM
Urethrography 2 wk
45
55
PS 23
(OM 22)
41
18
TA
8 penile
5 (bulbopenile)
17.7
LM
56
OM
LM
15
BM
BM or SG
Regular uroowmetry
Urethrography 6 mo
Uroowmetry 3, 6, and 12 mo, then annually
Urethrography 6 and 18 mo
Urethroscopy in last 45 cases
Uroowmetry 6 and 12 mo with symptom score
Uroowmetry 3 and 12 mo
Urethrography 2 wk, 3 and 12 mo
Urethroscopy 3 and 12 mo
Uroowmetry every 4, 8, 12 mo, then annually
Urethrography 3 wk
Urethrography if Qmax <12 ml/s
Uroowmetry 3 and 6 mo
Urethrography 3 wk, 3 and 6 mo
Recurrence on urethrography
Development of symptoms leading
to urethrogram or urethroscopy
to conrm recurrence
Need for ISD >6 mo
96.4
54.5
100
57.1
Restricturing
95
Symptomatic recurrence
88.2
Symptom recurrence or
inability to pass 16Ch catheter
85.7
Symptomatic recurrence
88
Abnormal voiding
Need for intervention
Abnormal voiding
Any instrumentation
Evidence of stricture on urethrography
Stenosis on urethrography
87 (includes
18 bulbar)
0
(33)
Abnormal voiding
Any instrumentation
Evidence of stricture on urethrography
Poor uroowmetry
Poor urethrography
Any instrumentation
Any instrumentation
55.5
(84)
30
100
70 Ventral onlay
66 Dorsal onlay
78
(82)
67
Any instrumentation
100
83.3 (includes
bulbar)
100 penile
60 bulbopenile
805
28 (patch)
11 (tube)
41
Success
rate, %
Denition of failure
806
PAS
LM
21.7
17.2
12
56
Xu et al. [18]
BM = buccal mucosa; IPSS = International Prostate Symptom Score; ISD = intermittent self-dilatation; LM = lingual mucosa; PAS = postauricular skin graft; PS = penile skin; PVRU = postvoid residual urine; Qmax = maximum
ow rate; SG = full-thickness skin graft; SIS = small intestinal submucosa; TA = tunica albuginea; TV = tunica vaginalis.
87 (includes
bulbar cases)
Not described
88 (includes
8 panurethral)
92
Qmax<15 ml/s, abnormal urethrogram
or urethroscopy, need for any intervention
Any instrumentation
Authors
Table 4 (Continued )
No. treated
Follow-up,
mo
Type of graft
Follow-up method
Denition of failure
Success
rate, %
807
Table 5 Outcomes and follow-up of penile urethroplasty via the two-stage technique
Authors
No.
treated
Follow-up,
mo
16
36
58
Dubey et al
[66]
15
Dubey et al
[80]
Type of graft
Follow-up method
BM
Not described
24.2
BM or
SG
BM
14
32.5
BM
5
6
15
36
17
56
BM
SG
OM
Denition of failure
Success
rate, %
93.8
Restricturing
98
Symptom recurrence
or inability to
pass 16Ch catheter
Symptomatic recurrence
86.7
Any instrumentation
Failure of graft take
Any instrumentation
78.6
80
100
73
BM = buccal mucosa; OM = oral mucosa; Qmax = maximum ow rate; SG = full-thickness skin graft.
Panurethral strictures
Other techniques
808
Followup, mo
24
4
8
(bulbopenile)
12
12
BM or
SG
BM
36.2
BM
19
BM
Xu et al. [29]
36
53.6
CM
Manoj
et al 2009 [23]
15
21.7
PAS
Kulkarni
et al 2009 [74]
12
22
OM
Xu et al. [27]
25
26.8
18
9 BM 2
7 LM 2
9 LM + BM
LM
Mathur and
Sharma [30]
86
36
Dubey et al
[66]
Type
of graft
TA
Follow-up method
Denition of failure
Success rate, %
Restricturing
91.7
92
Symptom recurrence or
inability to pass
16Ch catheter
Qmax <15 ml/s, abnormal
urethrogram/urethroscopy,
any intervention
Abnormal voiding;
any intervention
83.3
Any instrumentation
80
Any instrumentation
92
Any instrumentation
92
83.3 (includes
bulbar)
89.5
BM = buccal mucosa; CM = colonic mucosa; LM = lingual mucosa; OM = oral mucosa; PAS = postauricular skin graft; Qmax = maximum ow rate; SG = full-thickness skin graft; TA = tunica albuginea.
88 (includes
8 penile)
85.7
No. of
stages
Andrich
et al. [21]
Gupta et al. [83]
No.
treated
809
No.
treated
Follow-up,
mo
12
840
21
SIS
25
12
LM
45
42
BM
Type of
graft
Follow-up
method
10 PS
2 BM
Denition of failure
Uroowmetry at last
follow-up
Urethrography 7 wk
Urethroscopy in 4 cases
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 3 wk and
12 mo or if Qmax <14 ml/s
Urethroscopy 3 and 12 mo
Uroowmetry 3, 6, and 12 mo
Urethrography 3 wk, 3,
6, and 12 mo
Uroowmetry 3, 6, and
every 6 mo thereafter
Urethrography 3 wk
Urethroscopy 3 mo
Success rate, %
Any instrumentation
91.7
Abnormal voiding
Any instrumentation
Evidence of stricture
on urethrography
100
80
87
BM = buccal mucosa; LM = lingual mucosa; PS = penile skin; SIS = small intestinal mucosa.
No. treated
Follow-up, mo
Type of graft
21
SIS
48
22
BM
Follow-up method
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 3 wk and
12 mo or if Qmax <14 ml/s
Urethroscopy 3 and 12 mo
Uroowmetry 4, 8, 12 mo,
then annually
Urethrography 3 wk
IF Qmax <14 ml/s, then
urethrography and urethroscopy
Denition
of failure
Abnormal voiding
Any instrumentation
Evidence of stricture
on urethrography
Abnormal voiding;
need for instrumentation
Success
rate, %
100
89.6
Average follow-up, mo
(follow-up no. of patients)/
total no. of patients
Average success, %
(success no. of patients)/total no. of patients
563
934
6
432
129
240
89
53
34.42
42.2
77
32.8
22.2
30.11
28.9
21.91
88.84
88.37
83
75.68
90.54
88.16
86.69
90.58
4.
Discussion
810
85.7 (53.6)
85.7 (53.6)
67 (18)
89.5 (36)
82.2 (30.2)
100 (23)
100 (23)
100 (21.7)
92 (21.7)
80 (21.7)
88.7 (21.7)
100(3)
100(3)
100 (3)
84 (15.7)
80 (12)
88.2 (16.6)
83.3 (9)
84.4 (14.7)
91.8 (18.8)
91 (30.3)
100 (21)
100 (21)
50 (30.2)
81.1 (27.1)
91.2 (39.1)
88.4 (34)
83 (77)
87 (45)
89.6 (22)
90.6 (42.5)
86 (31.5)
86.3 (26.4)
87.3 (37.6)
79.9 (60.8)
90 (23)
69.4 (54)
79.8 (57.1)
95 (46)
100 (17)
96.2 (39.3)
Dorsal onlay bulbar
Ventral onlay bulbar
Lateral onlay bulbar
Asopa
Palminteri
One-stage penile
Two-stage penile
Panurethral
Total
Small intestinal
submucosa
Buccal
mucosa
Penile
skin
Full-thickness
skin graft
Technique
Table 10 Success rates and follow-up (months) by technique and type of graft
Lingual
mucosa
Tunica
vaginalis
Postauricular
skin
Bladder
mucosa
Tunica
albuginea
Colonic
mucosa
811
Advantages
Disadvantages
Full-thickness
skin graft
Small intestinal
submucosa
Lingual mucosa
Tunica vaginalis
Postauricular skin
Bladder mucosa
Tunica albuginea
(of the corpora)
Colonic mucosa
Large donor site morbidity; graft contracture; variable host response; mixed
reported success; needs vascular wound bed
Limited availability of tissue; donor site morbidity; thin and difcult to handle,
short follow-up
Limited data, short follow-up, limited availability of tissue
Limited data, short follow-up; contraindicated for use in strictures secondary to
lichen sclerosis
Large donor site morbidity; short follow-up
Limited data; problems if recurrence of stricture
Large donor site morbidity
suggested based on their actuarial evaluation that urethroplasties of all forms may fail after a considerable length
of time postoperatively with stricture recurrences uniformly distributed over time [42].
Jordan et al. [41] also argued that urethrography in the
postoperative period may be confusing and therefore
should be used with caution. In our opinion, endoscopic
evaluation provides the most reliable data in terms of type
of recurrence and complications, and it provides information on the state of the urethra and is often easier to
interpret accurately than urethrography. Recurrences can
be picked up more reliably earlier than if relying on flow
rates or symptom scores.
5.
Conclusions
812
one-stage penile urethroplasty using a ap or graft in a homogeneous series of patients. BJU Int 2008;102:85360.
[20] Kumar MR, Himanshu A, Sudarshan O. Technique of anterior urethroplasty using the tunica albuginea of the corpora cavernosa.
Asian J Surg 2008;31:1349.
[21] Andrich DE, Greenwell TJ, Mundy AR. The problems of penile
urethroplasty with particular reference to 2-stage reconstructions.
J Urol 2003;170:879.
[22] Radopoulos D, Tzakas C, Dimitriadis G, Vakalopoulos I, Ioannidis S,
Vasilakakis I. Dorsal on-lay preputial graft urethroplasty for anterior urethra strictures repair. Int Urol Nephrol 2007;39:497503.
References
[1] Mangera A, Chapple C. Management of anterior urethral stricture:
an evidence-based approach. Curr Opin Urol 2010;20:4538.
[2] Santucci RA, Mario LA, McAninch JW. Anastomotic urethroplasty for
bulbar urethral stricture: analysis of 168 patients. J Urol 2002; 167:
17159.
[3] Barbagli G, Guazzoni G, Lazzeri M. One-stage bulbar urethroplasty:
retrospective analysis of the results in 375 patients. Eur Urol
2008;53:82833.
[4] Morey AF, Kizer WS. Proximal bulbar urethroplasty via extended
anastomotic approachwhat are the limits? J Urol 2006;175:21459.
[27] Xu YM, Sa YL, Fu Q, Zhang J, Si JM, Liu ZS. Oral mucosal grafts
10403.
[30] Mathur RK, Sharma A. Tunica albuginea urethroplasty for panurethral strictures. Urol J 2010;7:1204.
[31] Bhargava S, Patterson JM, Inman RD, MacNeil S, Chapple CR. Tissueengineered buccal mucosa urethroplastyclinical outcomes. Eur
Urol 2008;53:126371.
[32] Asopa HS, Garg M, Singhal GG, Singh L, Asopa J, Nischal A. Dorsal
free graft urethroplasty for urethral stricture by ventral sagittal
urethrotomy approach. Urology 2001;58:6579.
[33] Palminteri E, Berdondini E, Colombo F, Austoni E. Small intestinal
submucosa (SIS) graft urethroplasty: short-term results. Eur Urol
2007;51:1695701.
[34] Barbagli G, Vallasciani S, Romano G, Fabbri F, Guazzoni G, Lazzeri M.
Morbidity of oral mucosa graft harvesting from a single cheek. Eur
Urol 2010;58:3341.
[35] Wood DN, Allen SE, Andrich DE, Greenwell TJ, Mundy AR. The
2008;54:33543.
[16] Fichtner J, Filipas D, Fisch M, Hohenfellner R, Thuroff JW. Long-term
outcome of ventral buccal mucosa onlay graft urethroplasty for
urethral stricture repair. Urology 2004;64:64850.
10711.
[40] Chapple CR, Goonesinghe SK, Nicholson T, De Nunzio C. The importance of endoscopic surveillance in the follow up of patients with
urethral stricture disease. J Urol 2002;167(Suppl):16.
[41] Jordan GH, Schlossberg SM, Devine CJ. Surgery of the penis and
urethra. In: Walsh PC, Retik AB, Darracott-Vaughan E, Wein AJ,
editors. Campbells urology. ed 7. Philadelphia, PA: Saunders; 1998.
p. 331694.
813
[61] Iselin CE, Webster GD. Dorsal onlay graft urethroplasty for repair of
bulbar urethral stricture. J Urol 1999;161:8158.
[62] Barbagli G, Palminteri E, Lazzeri M, Guazzoni G, Turini D. Long-term
outcome of urethroplasty after failed urethrotomy versus primary
repair. J Urol 2001;165:19189.
[63] Joseph JV, Andrich DE, Leach CJ, Mundy AR. Urethroplasty for
refractory anterior urethral stricture. J Urol 2002;167:1279.
13657.
[65] Raber M, Naspro R, Scapaticci E, et al. Dorsal onlay graft urethroplasty using penile skin or buccal mucosa for repair of bulbar
urethral stricture: results of a prospective single center study.
Eur Urol 2005;48:10137.
[66] Dubey D, Kumar A, Mandhani A, Srivastava A, Kapoor R, Bhandari
M. Buccal mucosal urethroplasty: a versatile technique for all
urethral segments. BJU Int 2005;95:6259.
[67] Barbagli G, De Stefani S, Sighinol MC, Annino F, Micali S, Bianchi G.
Bulbar urethroplasty with dorsal onlay buccal mucosal graft and
brin glue. Eur Urol 2006;50:46774.
[68] Donkov II, Bashir A, Elenkov CH, Panchev PK. Dorsal onlay augmen-
[48] Lewis JB, Wolgast KA, Ward JA, Morey AF. Outpatient anterior
urethroplasty: outcome analysis and patient selection criteria. J
Urol 2002;168:10246.
[49] Kane CJ, Tarman GJ, Summerton DJ, et al. Multi-institutional experience with buccal mucosa onlay urethroplasty for bulbar urethral
reconstruction. J Urol 2002;167:13147.
[50] Heinke T, Gerharz EW, Bong R, Riedmiller H. Ventral onlay urethroplasty using buccal mucosa for complex stricture repair. Urology 2003;61:10047.
[51] Pansadoro V, Emiliozzi P, Gaf M, Scarpone P, DePaula F, Pizzo M.
Buccal mucosa urethroplasty in the treatment of bulbar urethral
strictures. Urology 2003;61:100810.
[52] Elliott SP, Metro MJ, McAninch JW. Long-term followup of the
ventrally placed buccal mucosa onlay graft in bulbar urethral
reconstruction. J Urol 2003;169:17547.
2006;13:14157.
[69] Xu Y-M, Qiao Y, Sa Y-L, et al. Substitution urethroplasty of complex
and long-segment urethral strictures: a rationale for procedure
selection. Eur Urol 2007;51:10939.
[70] Foinquinos RC, Calado AA, Janio R, Griz A, Macedo Jr A, Ortiz V. The
tunica vaginalis dorsal graft urethroplasty: initial experience. Int
Braz J Urol 2007;33:5239.
[71] ORiordan A, Narahari R, Kumar V, Pickard R. Outcome of dorsal
buccal graft urethroplasty for recurrent bulbar urethral strictures.
BJU Int 2008;102:114851.
[72] Simonato A, Gregori A, Ambruosi C, et al. Lingual mucosal graft
urethroplasty for anterior urethral reconstruction. Eur Urol
2008;54:7987.
[73] Das SK, Kumar A, Sharma GK, et al. Lingual mucosal graft urethroplasty for anterior urethral strictures. Urology 2009;73:1058.
2009;104:11505.
[54] Kellner DS, Fracchia JA, Armenakas NA. Ventral onlay buccal mu-
mucosa grafts for repairing long bulbar urethral strictures. BJU Int
Urol 2004;171:7269.
2010;105:11702.
Urology 2006;68:11569.
46570.
[77] Arlen AM, Powell CR, Hoffman HT, Kreder KJ. Buccal mucosal graft
2007;51:17028.
[57] Levine LA, Strom KH, Lux MM. Buccal mucosa graft urethroplasty
749.
[78] Venn SN, Mundy AR. Early experience with the use of buccal
2007;178:20115.
73840.
[58] Dalela D, Sinha RJ, Sankhwar SN, Singh V. Ventral bulbar augmen-
[79] Metro MJ, Wu HY, Snyder III HM, Zderic SA, Canning DA. Buccal
2001;166:145961.
[80] Dubey D, Sehgal A, Srivastava A, Mandhani A, Kapoor R, Kumar A.
78:92932.
Urol 2005;173:4636.
[81] Singh BP, Pathak HR, Andankar MG. Dorsolateral onlay urethro-
814
[82] Meeks JJ, Erickson BA, Gonzalez CM. Full-thickness abdominal skin
graft for long-segment urethral stricture reconstruction. Int Braz J
Urol 2008;34:6027.
[83] Gupta NP, Ansari MS, Dogra PN, Tandon S. Dorsal buccal mucosal
graft urethroplasty by a ventral sagittal urethrotomy and minimal-